Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and Prospects.

Autor: Zhou, Hong (AUTHOR), Hu, Pan (AUTHOR), Yan, Xiyue (AUTHOR), Zhang, Yaping (AUTHOR), Shi, Wenyu (AUTHOR)
Zdroj: OncoTargets & Therapy. May2020, Vol. 13, p4877-4892. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje